Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07829471 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Routine Electronic Patient-Reported Outcome (ePRO)Symptom Monitoring During Neoadjuvant Therapy in Patients withPancreatic Adenocarcinoma on Patient Experience and ClinicalOutcomes: A Prospective Pre-Post Implementation Study

Name: Impact of Routine Electronic Patient-Reported Outcome (ePRO)Symptom Monitoring During Neoadjuvant Therapy in Patients withPancreatic Adenocarcinoma on Patient Experience and ClinicalOutcomes: A Prospective Pre-Post Implementation Study — clinical trial record (NCT07829471)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot applicable

SponsorM.D. Anderson Cancer Center

Started2027-02-21

View on ClinicalTrials.gov ↗

M.D. Anderson Cancer Center

1,223 trials monitored

See 78 trials at risk

Pancreatic Cancer

1,634 trials monitored

See 90 trials at risk

To learn if routine symptom monitoring using questionnaires during chemotherapy and/or radiation therapy in patients with PDAC improves patient health-related quality of life and experience with care.

Trial Details

NCT Number	NCT07829471
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	ePRO, Symptom Monitoring, Neoadjuvant Therapy, Pancreatic Adenocarcinoma, Clinical Outcomes
Enrollment	200 participants
Start Date	2027-02-21
Primary Completion	2030-07-01 (estimated)
Study Completion	2032-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-21